Therefore, we mapped co‐occurring mutational profiles as a function of TP53 allelic state (monoallelic vs. multihit) and absolute VAF (≤50% or >50%) for MDS (Figure 2C) and AML (Figure 2D). This evidence concerns the gene TP53 and acute myeloid leukemia.